Shingles and COVID-19
Recent large-scale observational studies conducted in the United States have suggested that COVID-19 may increase the risk of shingles in adults aged 50 and above. The development of shingles is linked to the reactivation of the varicella-zoster virus due to a weakened immune system. While these studies are from the United States, they have indicated a higher risk of shingles in individuals aged 50 and above who were diagnosed with COVID-19 compared to those who were not.
The Importance of Health Maintenance
To prevent shingles, it is essential to maintain good overall health. For individuals in their 20s to 40s, getting at least 6 hours of sleep per day is crucial. Those aged 50 and above should focus on not only sleep and rest but also incorporate regular physical activity, such as 5 minutes of daily exercise. A general precaution for all age groups is to avoid lifestyles that induce a drop in body temperature, as this can weaken the immune system. It is important to wear warm clothing, maintain room temperatures around 28 degrees Celsius, and be cautious about consuming excessive cold food and drinks.
Effective Treatments for Postherpetic Neuralgia After Shingles
The standard treatment for shingles involves using antiviral medications to suppress the replication of the varicella-zoster virus. Since shingles is often associated with severe pain, pain relievers are also used.
However, in some cases, pain relief may not be achieved, and hospitalization becomes necessary. One effective treatment option for shingles is acupuncture and blood stasis therapy. This treatment can lead to early relief or complete disappearance of pain. Administering this therapy shortly after the formation of blisters reduces the likelihood of transitioning to postherpetic neuralgia.